HIV Drugs and Injectables Market Report 2024-2034: U.S. Targets to End the HIV Epidemic in the Country by 2030 Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "HIV Drugs and Injectables Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the HIV Drugs &...

Global Diagnostics and Therapeutics for HIV Market Expected to Reach $39.3 Billion by 2028: Advancements in Diagnostic Technologies Drive Growth Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Diagnostics and Therapeutics for HIV: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global diagnostics and...

Global HIV Drugs Market Research Report 2023-2031: Antiretroviral Therapy (ART) Emerging as Pivotal Tool in Managing HIV and Enhancing Well-Being Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global HIV Drugs Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global HIV drugs market value...

Global and Historical Trends - HIV Epidemiology Forecasts to 2029 Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Human Immunodeficiency Virus (HIV) - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. The total prevalent...

Human Immunodeficiency Virus Type-1 (HIV-1) Industry Landscape Report 2021-2030 Featuring Insights Into Lenacapavir (GS-6207), GSK3640254 (GSK'254), and MK-8591A (Islatravir/doravirine; DOR/ISL) Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Human Immunodeficiency Virus Type-1 (HIV-1) - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to...